| Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Net income (loss) | 192 | 224 | 227 | 210 | 304 | 332 | -212 | 928 | 1,727 | 488 | -945 | 1,218 |
---|
Net earnings from discontinued operations, net of income taxes | - | - | - | - | 12 | 11 | - | - | 16 | - | - | - |
---|
Realized losses (gains) on sale of investments | 74 | 71 | - | - | - | - | - | - | - | - | -135 | -65 |
---|
Realized losses on investments | - | - | - | - | - | - | - | - | - | -58 | - | - |
---|
Variable Interest Entity, Primary Beneficiary | - | - | - | - | - | - | - | - | - | - | - | 6 |
---|
Unrealized losses (gains) on investments | - | - | - | - | - | - | - | - | - | 178 | -1,479 | 528 |
---|
Unrealized (gains) losses on investments | - | - | - | - | - | - | - | - | - | - | - | 114 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Net gain on Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 275 |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Cash consideration for the Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 94 |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Realized losses (gains) on sale of investments | 74 | 71 | - | - | - | - | - | - | - | - | -135 | -65 |
---|
Realized losses on investments | - | - | - | - | - | - | - | - | - | -58 | - | - |
---|
Variable Interest Entity, Primary Beneficiary | - | - | - | - | - | - | - | - | - | - | - | 6 |
---|
Unrealized losses (gains) on investments | - | - | - | - | - | - | - | - | - | 178 | -1,479 | 528 |
---|
Unrealized (gains) losses on investments | - | - | - | - | - | - | - | - | - | - | - | 114 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Net gain on Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 275 |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Cash consideration for the Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 94 |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net cash flows provided by operating activities | -187 | -62 | - | - | -203 | -343 | -160 | 1,764 | - | - | - | 523 |
---|
Net cash flows provided by operating activities | - | - | 498 | -739 | - | - | - | - | 2,786 | 3,801 | 257 | - |
---|
Acquisition, net of cash acquired | - | 410 | -38 | -110 | 18 | 4 | 245 | -172 | - | 206 | - | - |
---|
Sales of subsidiaries, net of cash previously held | - | - | - | - | - | - | - | - | -14 | -214 | - | - |
---|
Sales and maturities of available-for-sale securities | 354 | 197 | 110 | 143 | 82 | 86 | 58 | 344 | 2,260 | 3,085 | 2,502 | 2,132 |
---|
Purchase of available-for-sale securities | - | - | - | - | - | - | 10 | 2,212 | 4,181 | 5,233 | 2,295 | 1,959 |
---|
Purchase of other investments | 198 | 107 | 350 | 355 | 91 | 110 | 901 | 797 | 975 | 910 | 1,552 | 911 |
---|
Proceeds from other investments | 0 | 29 | 105 | 169 | 245 | 233 | 436 | 583 | 595 | 330 | 420 | 530 |
---|
Other investing activities | 1 | -2 | -1 | 2 | 8 | 24 | 8 | 5 | -1 | -1 | -6 | -12 |
---|
Sale of equity method investment | - | - | - | - | - | - | - | - | 12 | - | - | 48 |
---|
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15) | - | - | - | - | - | - | - | - | - | -574 | - | - |
---|
Other investing activities | 1 | -2 | -1 | 2 | 8 | 24 | 8 | 5 | -1 | -1 | -6 | -12 |
---|
Net cash flows used in investing activities | - | - | -292 | 487 | - | - | - | - | -2,335 | -2,573 | -919 | - |
---|
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15) | - | - | - | - | - | - | - | - | - | -574 | - | - |
---|
Net cash flows used in investing activities | 229 | -366 | - | - | 157 | 293 | -826 | -1,984 | - | - | - | -148 |
---|
Dividends on preferred shares | - | - | - | - | - | - | 12 | 36 | 36 | 36 | 36 | 36 |
---|
Dividends paid to noncontrolling interests | 69 | 4 | 18 | 17 | - | 27 | 4 | 12 | 0 | 1 | 55 | - |
---|
Repurchase of shares | - | - | - | - | - | - | - | - | 26 | 942 | 163 | 531 |
---|
Proceeds from (Payments to) Noncontrolling Interests | - | - | - | - | - | - | - | - | - | - | - | -294 |
---|
Issuance of debt, net of issuance costs | - | 370 | 70 | 658 | 571 | 874 | 1,133 | 1,071 | 859 | 816 | 494 | - |
---|
Repurchase of shares | - | - | - | - | - | - | - | - | 26 | 942 | 163 | 531 |
---|
Repayment of debt | 135 | 40 | 199 | 378 | 493 | 912 | 914 | 743 | 679 | 574 | 356 | - |
---|
Issuance of debt, net of issuance costs | - | 370 | 70 | 658 | 571 | 874 | 1,133 | 1,071 | 859 | 816 | 494 | - |
---|
Net cash flows (used in) provided by financing activities | -234 | 423 | - | - | 83 | -65 | 753 | 294 | - | - | -116 | -861 |
---|
Repayment of debt | 135 | 40 | 199 | 378 | 493 | 912 | 914 | 743 | 679 | 574 | 356 | - |
---|
Net cash flows (used in) provided by financing activities | -234 | 423 | - | - | 83 | -65 | 753 | 294 | - | - | -116 | -861 |
---|
Net cash flows provided by operating activities | - | - | - | - | - | - | - | - | 108 | - | - | - |
---|
Net cash flows used in investing activities | - | - | - | - | - | - | - | - | -130 | - | - | - |
---|
Net cash flows from discontinued operations | - | - | - | - | - | - | - | - | -22 | - | - | - |
---|
EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH, CASH EQUIVALENTS AND RESTRICTED CASH | - | - | - | - | -14 | 10 | 3 | -0 | -6 | 4 | 16 | -14 |
---|
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | - | - | - | - | 23 | -106 | -230 | 73 | 541 | 495 | -762 | -500 |
---|
NET CHANGE IN CASH OF BUSINESSES HELD-FOR-SALE | - | - | - | - | - | - | - | - | -139 | 224 | - | - |
---|
Income Taxes Paid, Net | - | - | - | - | 22 | 13 | 18 | 5 | 25 | 10 | 3 | 16 |
---|
Interest paid | - | - | - | - | - | - | 25 | 49 | 51 | 64 | 86 | 88 |
---|
Novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 828 |
---|
Funds held directly managed transferred in exchange on novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 949 |
---|
Other assets / liabilities transferred on novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 62 |
---|
Noncash Losses And Loss Adjustment Expenses Transferred In Connection With Settlement Of Syndicate | - | - | - | - | - | - | - | - | - | - | - | 173 |
---|
Investments transferred in connection with settlement of participation in Atrium's Syndicate 609 | - | - | - | - | - | - | - | - | - | - | - | 173 |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Unsettled purchases of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 5 |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Unsettled sales of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities | - | - | - | - | - | - | - | - | - | - | - | 113 |
---|
Contribution to other investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Transfer To Other Investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Settlement of loan receivable as partial consideration for RNCI redemption | - | - | - | - | - | - | - | - | - | - | - | 15 |
---|
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest | - | - | - | - | - | - | - | - | - | - | - | 48 |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Unsettled purchases of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 5 |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Unsettled sales of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities | - | - | - | - | - | - | - | - | - | - | - | 113 |
---|
Contribution to other investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Transfer To Other Investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Settlement of loan receivable as partial consideration for RNCI redemption | - | - | - | - | - | - | - | - | - | - | - | 15 |
---|
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest | - | - | - | - | - | - | - | - | - | - | - | 48 |
---|
Net income (loss) | 192 | 224 | 227 | 210 | 304 | 332 | -212 | 928 | 1,727 | 488 | -945 | 1,218 |
---|
Net earnings from discontinued operations, net of income taxes | - | - | - | - | 12 | 11 | - | - | 16 | - | - | - |
---|
Realized losses (gains) on sale of investments | 74 | 71 | - | - | - | - | - | - | - | - | -135 | -65 |
---|
Realized losses on investments | - | - | - | - | - | - | - | - | - | -58 | - | - |
---|
Variable Interest Entity, Primary Beneficiary | - | - | - | - | - | - | - | - | - | - | - | 6 |
---|
Unrealized losses (gains) on investments | - | - | - | - | - | - | - | - | - | 178 | -1,479 | 528 |
---|
Unrealized (gains) losses on investments | - | - | - | - | - | - | - | - | - | - | - | 114 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Net gain on Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 275 |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Cash consideration for the Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 94 |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Realized losses (gains) on sale of investments | 74 | 71 | - | - | - | - | - | - | - | - | -135 | -65 |
---|
Realized losses on investments | - | - | - | - | - | - | - | - | - | -58 | - | - |
---|
Variable Interest Entity, Primary Beneficiary | - | - | - | - | - | - | - | - | - | - | - | 6 |
---|
Unrealized losses (gains) on investments | - | - | - | - | - | - | - | - | - | 178 | -1,479 | 528 |
---|
Unrealized (gains) losses on investments | - | - | - | - | - | - | - | - | - | - | - | 114 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Amortization of net deferred charge assets | - | - | - | - | - | - | - | - | - | - | 80 | 106 |
---|
Depreciation and other amortization | 1 | 1 | 6 | 55 | 35 | 32 | 33 | 36 | 60 | 74 | 49 | 7 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Net gain on Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 275 |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Cash consideration for the Enhanzed Re novation | - | - | - | - | - | - | - | - | - | - | - | 94 |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
(Income) losses from equity method investments | - | - | - | - | - | - | 42 | 56 | 239 | 93 | -74 | 13 |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Sales and maturities of trading securities | 2,469 | 2,680 | 2,974 | 3,913 | 3,407 | 5,743 | 4,802 | 5,829 | 3,792 | 6,175 | 2,840 | 1,530 |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Purchases of trading securities | 2,619 | 2,714 | 2,088 | 4,264 | 3,101 | 7,024 | 5,592 | 4,591 | 2,139 | 3,064 | 1,849 | 492 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Payments to cover securities sold short | - | - | - | - | - | - | - | - | - | 1,156 | - | - |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Proceeds from securities sold short | - | - | - | - | - | - | - | - | - | 534 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Net payments for derivative contracts | - | - | - | - | - | - | - | - | - | 94 | - | - |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net gain on purchase and sales of subsidiaries | - | - | - | - | - | - | - | - | - | 73 | - | - |
---|
Other adjustments | - | - | - | - | -9 | -15 | -12 | -34 | -23 | -30 | -13 | -5 |
---|
Reinsurance balances recoverable on paid and unpaid losses | -667 | -431 | -435 | -403 | 22 | 531 | 268 | 350 | -52 | -248 | -375 | -142 |
---|
Funds held | 258 | -176 | -114 | -35 | 967 | 279 | 127 | 87 | 192 | 1,491 | 1,241 | 338 |
---|
Losses and loss adjustment expenses | - | - | - | - | 259 | 1,363 | 960 | 1,021 | 1,003 | 1,870 | -151 | -624 |
---|
Defendant asbestos and environmental liabilities | - | - | - | - | - | - | - | -18 | -141 | -68 | -31 | -40 |
---|
Insurance and reinsurance balances payable | -65 | - | - | - | 121 | -158 | 152 | -15 | 87 | -300 | -154 | -23 |
---|
Other operating assets and liabilities | - | - | - | - | 151 | -261 | 245 | -54 | -389 | -514 | 417 | 353 |
---|
Net cash flows provided by operating activities | -187 | -62 | - | - | -203 | -343 | -160 | 1,764 | - | - | - | 523 |
---|
Net cash flows provided by operating activities | - | - | 498 | -739 | - | - | - | - | 2,786 | 3,801 | 257 | - |
---|
Acquisition, net of cash acquired | - | 410 | -38 | -110 | 18 | 4 | 245 | -172 | - | 206 | - | - |
---|
Sales of subsidiaries, net of cash previously held | - | - | - | - | - | - | - | - | -14 | -214 | - | - |
---|
Sales and maturities of available-for-sale securities | 354 | 197 | 110 | 143 | 82 | 86 | 58 | 344 | 2,260 | 3,085 | 2,502 | 2,132 |
---|
Purchase of available-for-sale securities | - | - | - | - | - | - | 10 | 2,212 | 4,181 | 5,233 | 2,295 | 1,959 |
---|
Purchase of other investments | 198 | 107 | 350 | 355 | 91 | 110 | 901 | 797 | 975 | 910 | 1,552 | 911 |
---|
Proceeds from other investments | 0 | 29 | 105 | 169 | 245 | 233 | 436 | 583 | 595 | 330 | 420 | 530 |
---|
Other investing activities | 1 | -2 | -1 | 2 | 8 | 24 | 8 | 5 | -1 | -1 | -6 | -12 |
---|
Sale of equity method investment | - | - | - | - | - | - | - | - | 12 | - | - | 48 |
---|
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15) | - | - | - | - | - | - | - | - | - | -574 | - | - |
---|
Other investing activities | 1 | -2 | -1 | 2 | 8 | 24 | 8 | 5 | -1 | -1 | -6 | -12 |
---|
Net cash flows used in investing activities | - | - | -292 | 487 | - | - | - | - | -2,335 | -2,573 | -919 | - |
---|
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15) | - | - | - | - | - | - | - | - | - | -574 | - | - |
---|
Net cash flows used in investing activities | 229 | -366 | - | - | 157 | 293 | -826 | -1,984 | - | - | - | -148 |
---|
Dividends on preferred shares | - | - | - | - | - | - | 12 | 36 | 36 | 36 | 36 | 36 |
---|
Dividends paid to noncontrolling interests | 69 | 4 | 18 | 17 | - | 27 | 4 | 12 | 0 | 1 | 55 | - |
---|
Repurchase of shares | - | - | - | - | - | - | - | - | 26 | 942 | 163 | 531 |
---|
Proceeds from (Payments to) Noncontrolling Interests | - | - | - | - | - | - | - | - | - | - | - | -294 |
---|
Issuance of debt, net of issuance costs | - | 370 | 70 | 658 | 571 | 874 | 1,133 | 1,071 | 859 | 816 | 494 | - |
---|
Repurchase of shares | - | - | - | - | - | - | - | - | 26 | 942 | 163 | 531 |
---|
Repayment of debt | 135 | 40 | 199 | 378 | 493 | 912 | 914 | 743 | 679 | 574 | 356 | - |
---|
Issuance of debt, net of issuance costs | - | 370 | 70 | 658 | 571 | 874 | 1,133 | 1,071 | 859 | 816 | 494 | - |
---|
Net cash flows (used in) provided by financing activities | -234 | 423 | - | - | 83 | -65 | 753 | 294 | - | - | -116 | -861 |
---|
Repayment of debt | 135 | 40 | 199 | 378 | 493 | 912 | 914 | 743 | 679 | 574 | 356 | - |
---|
Net cash flows (used in) provided by financing activities | -234 | 423 | - | - | 83 | -65 | 753 | 294 | - | - | -116 | -861 |
---|
EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH, CASH EQUIVALENTS AND RESTRICTED CASH | - | - | - | - | -14 | 10 | 3 | -0 | -6 | 4 | 16 | -14 |
---|
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | - | - | - | - | 23 | -106 | -230 | 73 | 541 | 495 | -762 | -500 |
---|
Income Taxes Paid, Net | - | - | - | - | 22 | 13 | 18 | 5 | 25 | 10 | 3 | 16 |
---|
Interest paid | - | - | - | - | - | - | 25 | 49 | 51 | 64 | 86 | 88 |
---|
Novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 828 |
---|
Funds held directly managed transferred in exchange on novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 949 |
---|
Other assets / liabilities transferred on novation of future policy holder benefits | - | - | - | - | - | - | - | - | - | - | - | 62 |
---|
Noncash Losses And Loss Adjustment Expenses Transferred In Connection With Settlement Of Syndicate | - | - | - | - | - | - | - | - | - | - | - | 173 |
---|
Investments transferred in connection with settlement of participation in Atrium's Syndicate 609 | - | - | - | - | - | - | - | - | - | - | - | 173 |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Unsettled purchases of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 5 |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Unsettled sales of available-for-sale securities and other investments | - | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities | - | - | - | - | - | - | - | - | - | - | - | 113 |
---|
Contribution to other investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities | - | - | - | - | - | - | - | - | - | - | 508 | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Removal of equity method investment relating to acquisition of a subsidiary | - | - | - | - | - | - | - | - | - | -412 | - | - |
---|
Transfer to Investments | - | - | - | - | - | - | - | - | - | 52 | - | - |
---|
Transfer To Other Investments | - | - | - | - | - | - | - | - | - | 481 | - | - |
---|
Redemption of other investments | - | - | - | - | - | - | - | - | - | 381 | - | - |
---|
Settlement of loan receivable as partial consideration for RNCI redemption | - | - | - | - | - | - | - | - | - | - | - | 15 |
---|
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest | - | - | - | - | - | - | - | - | - | - | - | 48 |
---|